{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:28:54Z","timestamp":1782275334813,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.phrs.2020.105360","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T12:34:13Z","timestamp":1607430853000},"page":"105360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients"],"prefix":"10.1016","volume":"164","author":[{"given":"Bohan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2020.105360_bib0005","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105360_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"79","author":"Portman","year":"2014","journal-title":"Maturitas"},{"issue":"11","key":"10.1016\/j.phrs.2020.105360_bib0015","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/GME.0000000000001241","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"25","year":"2018","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.phrs.2020.105360_bib0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women\u2019s Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.phrs.2020.105360_bib0025","first-page":"h6364","article-title":"Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients","volume":"351","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.phrs.2020.105360_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1611","article-title":"Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: a systematic review and network meta-analysis","volume":"3","author":"Chang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.phrs.2020.105360_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/lsm.23220","article-title":"Efficacy of fractional CO laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial","author":"Aguiar","year":"2020","journal-title":"Lasers Surg. Med."},{"issue":"9","key":"10.1016\/j.phrs.2020.105360_bib0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/GME.0000000000000428","article-title":"Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)","volume":"22","author":"Archer","year":"2015","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.phrs.2020.105360_bib0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","article-title":"Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally","volume":"16","author":"Bachmann","year":"2009","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.phrs.2020.105360_bib0050","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.phrs.2020.105360_bib0055","first-page":"643","article-title":"Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)","volume":"26","author":"Barton","year":"2018","journal-title":"Support. Care Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2020.105360_bib0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","article-title":"Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105360_bib0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","article-title":"Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women","volume":"23","author":"Bygdeman","year":"1996","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.phrs.2020.105360_bib0070","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/jsm.12125","article-title":"Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial","volume":"10","author":"Chen","year":"2013","journal-title":"J. Sex Med."},{"issue":"2","key":"10.1016\/j.phrs.2020.105360_bib0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/13697137.2014.954996","article-title":"Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial","volume":"18","author":"Constantine","year":"2015","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.phrs.2020.105360_bib0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/GME.0000000000000786","article-title":"The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy","volume":"24","author":"Constantine","year":"2017","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.phrs.2020.105360_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.phrs.2020.105360_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.GME.0000077620.13164.62","article-title":"Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women","volume":"11","author":"Dessole","year":"2004","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.phrs.2020.105360_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(92)90059-8","article-title":"Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study","volume":"44","author":"Eriksen","year":"1992","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105360_bib0100","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/jsm.12473","article-title":"Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial","volume":"11","author":"Fernandes","year":"2014","journal-title":"J. Sex Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.105360_bib0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/13697137.2015.1045485","article-title":"Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause","volume":"18","author":"Gambacciani","year":"2015","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.phrs.2020.105360_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/lsm.22569","article-title":"Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause","volume":"49","author":"Gaspar","year":"2017","journal-title":"Lasers Surg. Med."},{"issue":"9","key":"10.1016\/j.phrs.2020.105360_bib0115","article-title":"Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal\/vulvar health indices","volume":"26","author":"Goldstein","year":"2019","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.phrs.2020.105360_bib0120","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.maturitas.2011.12.022","article-title":"Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2Mg and 0.03mg estriol","volume":"71","author":"Griesser","year":"2012","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.phrs.2020.105360_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0000000000000571","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"23","author":"Labrie","year":"2016","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.phrs.2020.105360_bib0130","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/jsm.13045","article-title":"Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy","volume":"12","author":"Labrie","year":"2015","journal-title":"J. Sex Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105360_bib0135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1997.15.3.969","article-title":"Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer","volume":"15","author":"Loprinzi","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105360_bib0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamainternmed.2018.0116","article-title":"Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial","volume":"178","author":"Mitchell","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105360_bib0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: replens versus local estrogen in menopausal women","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.phrs.2020.105360_bib0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial","volume":"27","author":"Paraiso","year":"2020","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.phrs.2020.105360_bib0155","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial","volume":"26","author":"Politano","year":"2019","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.phrs.2020.105360_bib0160","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.phrs.2020.105360_bib0165","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.phrs.2020.105360_bib0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/gme.0b013e31826d36ba","article-title":"One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.phrs.2020.105360_bib0175","first-page":"823","article-title":"Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms","volume":"102","author":"Speroff","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.phrs.2020.105360_bib0180","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2020.105360_bib0185","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","volume":"10","author":"Cody","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2020.105360_bib0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2017.06.029","article-title":"Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis","volume":"103","author":"Pitsouni","year":"2017","journal-title":"Maturitas"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:18:39Z","timestamp":1760912319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820316686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"alternative-id":["S1043661820316686"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105360","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105360"}}